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Our laboratory is blending new RNA chemistries, largely
directed at the ribose 2’-hydroxyl group, with quantita-
tive interpretation to create new kinds of chemical
microscopes for accurate RNA structure analysis. This
seminar will focus on two examples from retroviral biol-
ogy. All retroviral RNAs contain a packaging element
that directs the genome into nascent virus particles
through a mechanism that has been unclear. Using
SHAPE, we probed the structure of murine leukemia
virus RNA inside virus particles and identified the bind-
ing site for the nucleocapsid domain of Gag. The RNA
structural context is critical: High-affinity binding
requires two specific UCUG-UR-UCUG motifs flanked
by base-paired elements. Mutation of four guanosine
residues in these two motifs - only 4 nucleotides per
genomic RNA - reduced packaging to non-specific
levels. These motifs only form in genomic RNA dimers;
thus analysis of authentic full-length RNA was critical.
This work illustrates how local context and RNA struc-
ture can create information-rich recognition signals
from simple single-stranded sequence elements. In the
second example, we discovered strong correlations
between shRNA-mediated inhibition of HIV-1 replica-
tion in a cell-based assay and both the energetic cost of
breaking secondary structures and the overall annealing
energy between guide strand and folded target RNA.
T h e s ec o r r e l a t i o n sw e r eo n l ya p p a r e n tw h e nt h ee n e r -
getic cost of disrupting pre-existing structure in the
HIV-1 RNA was calculated using a secondary structure
model derived from SHAPE probing information. We
verified these correlations by design and evaluation of
additional shRNAs and could achieve consistent inhibi-
tion of HIV-1 production by 90%. This approach
emphasizes the profound, but ultimately predictable,
role of RNA structure in tuning RNAi function and is
likely to prove broadly useful in understanding large-
scale biological recognition involving RNA.
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